Literature DB >> 16861894

BRCA1-mediated ubiquitylation.

Simon J Boulton1.   

Abstract

The BRCA1 tumour suppressor and its heterodimeric partner BARD1 play crucial roles in coordinating cellular responses to DNA damage. Evidence also implicates these proteins in transcriptional regulation, cell cycle progression and meiotic sex chromosome inactivation, but their mode of action remains elusive. The demonstration that the BRCA1/BARD1 heterodimer constitutes an E3-ubiquitin (Ub) ligase raises the possibility that ubiquitylation of specific targets may allow BRCA1/BARD1 to impact on diverse cellular processes. It is clear that the E3-Ub ligase activity of BRCA1/BARD1 is of critical functional importance as tumour-derived BRCA1 mutations have been identified that eliminate this activity. Recent work and data presented here indicates that BRCA1/BARD1 function is largely conserved in C. elegans. Indeed, studies in C. elegans and human cells have illuminated how the E3-ubiquitin (Ub) ligase activity is regulated in response to DNA damage. However, bone fide targets for BRCA1-dependent ubiquitylation are not known and their identification remains critical to the understanding of the role of BRCA1 in tumorigenesis.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16861894     DOI: 10.4161/cc.5.14.2930

Source DB:  PubMed          Journal:  Cell Cycle        ISSN: 1551-4005            Impact factor:   4.534


  19 in total

1.  BRCA1 modulates the expression of hnRNPA2B1 and KHSRP.

Authors:  Manuela Santarosa; Laura Del Col; Alessandra Viel; Nicoletta Bivi; Chiara D'Ambrosio; Andrea Scaloni; Gianluca Tell; Roberta Maestro
Journal:  Cell Cycle       Date:  2010-12-01       Impact factor: 4.534

2.  A single unpaired and transcriptionally silenced X chromosome locally precludes checkpoint signaling in the Caenorhabditis elegans germ line.

Authors:  Aimee Jaramillo-Lambert; JoAnne Engebrecht
Journal:  Genetics       Date:  2009-12-14       Impact factor: 4.562

3.  Wild-type BRCA1, but not mutated BRCA1, regulates the expression of the nuclear form of beta-catenin.

Authors:  Huchun Li; Masayuki Sekine; Nadine Tung; Hava Karsenty Avraham
Journal:  Mol Cancer Res       Date:  2010-03-09       Impact factor: 5.852

Review 4.  Ubiquitin becomes ubiquitous in cancer: emerging roles of ubiquitin ligases and deubiquitinases in tumorigenesis and as therapeutic targets.

Authors:  Dingding Shi; Steven R Grossman
Journal:  Cancer Biol Ther       Date:  2010-10-15       Impact factor: 4.742

Review 5.  The importance of being flexible: the case of basic region leucine zipper transcriptional regulators.

Authors:  Maria Miller
Journal:  Curr Protein Pept Sci       Date:  2009-06       Impact factor: 3.272

6.  MERIT40 facilitates BRCA1 localization and DNA damage repair.

Authors:  Lin Feng; Jun Huang; Junjie Chen
Journal:  Genes Dev       Date:  2009-03-04       Impact factor: 11.361

7.  Altered adenosine-to-inosine RNA editing in human cancer.

Authors:  Nurit Paz; Erez Y Levanon; Ninette Amariglio; Amy B Heimberger; Zvi Ram; Shlomi Constantini; Zohar S Barbash; Konstantin Adamsky; Michal Safran; Avi Hirschberg; Meir Krupsky; Issachar Ben-Dov; Simona Cazacu; Tom Mikkelsen; Chaya Brodie; Eli Eisenberg; Gideon Rechavi
Journal:  Genome Res       Date:  2007-10-01       Impact factor: 9.043

8.  Meiotic Double-Strand Break Processing and Crossover Patterning Are Regulated in a Sex-Specific Manner by BRCA1-BARD1 in Caenorhabditis elegans.

Authors:  Qianyan Li; Sara Hariri; JoAnne Engebrecht
Journal:  Genetics       Date:  2020-08-12       Impact factor: 4.562

9.  Fluorescent oligonucleotides can serve as suitable alternatives to radiolabeled oligonucleotides.

Authors:  Rahul Ballal; Amrita Cheema; Waaqar Ahmad; Eliot M Rosen; Tapas Saha
Journal:  J Biomol Tech       Date:  2009-09

10.  A comprehensive framework of E2-RING E3 interactions of the human ubiquitin-proteasome system.

Authors:  Sjoerd J L van Wijk; Sjoerd J de Vries; Patrick Kemmeren; Anding Huang; Rolf Boelens; Alexandre M J J Bonvin; H Th Marc Timmers
Journal:  Mol Syst Biol       Date:  2009-08-18       Impact factor: 11.429

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.